The next board meeting for Aclaris Therapeutics Inc is on 09 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment ConferenceSee details
Aclaris Therapeutics Inc has a share price target of US$ 8, revenue growth forecast of -66.1%, and profit growth estimate of 51.6% for FY25, based on top 8 analyst calls.